Publisher
Springer Science and Business Media LLC
Subject
Molecular Biology,Applied Microbiology and Biotechnology,Biochemistry,Bioengineering,Biotechnology
Reference38 articles.
1. Liu, C., Wang, W., Lin, P., Xie, H., Jiang, S., Jia, H., Li, R., Wang, N., & Xiaoguang, Yu. (2021). GDI2 is a target of paclitaxel that affects tumorigenesis of prostate cancer via the p75NTR signaling pathway. Biochemical and Biophysical Research Communications., 562, 119–126.
2. Siegel, R. L., Miller, K. D., & Jemal, A. (2016). Cancer statistics, 2016. CA: A Cancer Journal for Clinicians, 66, 7–30.
3. Adamaki, M., & Zoumpourlis, V. (2021). Prostate cancer biomarkers: From diagnosis to prognosis and precision-guided therapeutics. Pharmacology & Therapeutics, 228, 107932.
4. Rebello, R. J., Oing, C., Knudsen, K. E., Loeb, S., Johnson, D. C., Reiter, R. E., Gillessen, S., Van der Kwast, T., & Bristow, R. G. (2021). Prostate cancer. Nature Reviews Disease Primers, 7, 9.
5. Sandhu, S., Moore, C. M., Chiong, E., Beltran, H., Bristow, R. G., & Williams, S. G. (2021). Prostate cancer. Lancet, 398, 1075–1090.